Home
Tang Capital Partners, 10% Owner: TCR2 Therapeutics TCRR Buy · Filed 23/05/30
Trade details
- Type
- Insider buy
- Amount
- $86,000
- Shares · price
- 50,000 sh · $1.72 a share
- Held after
- 4,394,800 sh
- Trade date
- 23/05/25
- Filed
- 23/05/30
- Days to filing
- 5 days
3 insiders bought this week
- Insiders buying this week
- 3 insiders
- Holding change
- +1.2%
TCR2 Therapeutics trades, last 26 weeks
What else happened in TCR2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/04/25~23/06/24Tang Capital Partners's recent trades
- Tang Capital Partners
BuySingular Genomics Systems
BuySingular Genomics Systems
OMIC
$642.3K
50,416 sh
$642.3K
Filed 24/09/18
Traded 24/09/16
- Tang Capital Partners
BuySingular Genomics Systems
BuySingular Genomics Systems
OMIC
$613.2K
40,000 sh
$613.2K
Filed 24/09/18
Traded 24/09/17
- Tang Capital Partners
BuySingular Genomics Systems
BuySingular Genomics Systems
OMIC
$550.7K
32,000 sh
$550.7K
Filed 24/09/18
Traded 24/09/18
- Tang Capital Partners
SellRain Oncology
SellRain Oncology
RAIN
$131.3K
109,435 sh
$131.3K
Filed 23/12/18
Traded 23/12/15
- Tang Capital Partners
SellRain Oncology
SellRain Oncology
RAIN
$48.6K
40,132 sh
$48.6K
Filed 23/12/18
Traded 23/12/18